Ciphergen and Ohio State University Research Foundation Sign Collaborative Agreement to Develop Diagnostic Test for Blood Disorder

Teaser:

FREMONT, Calif., Nov. 28 /PRNewswire-FirstCall/ — Ciphergen Biosystems, Inc. (Nasdaq: CIPH) and Ohio State University Research Foundation (OSURF) today announced a collaborative agreement to develop and clinically validate a diagnostic test to detect thrombotic thrombocytopenic purpura (TTP), a hematologic disease.

Source: Ciphergen